Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Nurix Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
170
−3 vs. Q4 2024
Shares held
84.6M
+3.91M (+4.8%) vs. Q4 2024
Total value
$1.01B
−$515.2M (−33.9%) vs. Q4 2024
New holders
29
66 more added
Sold out
32
51 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 170 institutions
Q1 2021: 101 institutionsQ2 2021: 104 institutionsQ3 2021: 113 institutionsQ4 2021: 125 institutionsQ1 2022: 117 institutionsQ2 2022: 106 institutionsQ3 2022: 118 institutionsQ4 2022: 119 institutionsQ1 2023: 124 institutionsQ2 2023: 126 institutionsQ3 2023: 129 institutionsQ4 2023: 131 institutionsQ1 2024: 139 institutionsQ2 2024: 174 institutionsQ3 2024: 172 institutionsQ4 2024: 175 institutionsQ1 2025: 170 institutionsQ2 2025: 164 institutionsQ3 2025: 173 institutionsQ4 2025: 182 institutionsQ1 2026: 196 institutionsQ2 2026: 211 institutions
Value heldQ1 2025: $1.01B
Q1 2021: $1.29BQ2 2021: $1.05BQ3 2021: $1.18BQ4 2021: $1.17BQ1 2022: $565.6MQ2 2022: $568.4MQ3 2022: $561.0MQ4 2022: $468.6MQ1 2023: $376.6MQ2 2023: $435.7MQ3 2023: $352.5MQ4 2023: $475.6MQ1 2024: $721.3MQ2 2024: $1.36BQ3 2024: $1.53BQ4 2024: $1.53BQ1 2025: $1.01BQ2 2025: $1.01BQ3 2025: $783.3MQ4 2025: $2.15BQ1 2026: $1.81BQ2 2026: $2.84B
Institutions holding NRIX and their total value by quarter
QuarterHoldersValue
Q2 2026211$2.84B
Q1 2026196$1.81B
Q4 2025182$2.15B
Q3 2025173$783.3M
Q2 2025164$1.01B
Q1 2025170$1.01B
Q4 2024175$1.53B
Q3 2024172$1.53B
Q2 2024174$1.36B
Q1 2024139$721.3M
Q4 2023131$475.6M
Q3 2023129$352.5M
Q2 2023126$435.7M
Q1 2023124$376.6M
Q4 2022119$468.6M
Q3 2022118$561.0M
Q2 2022106$568.4M
Q1 2022117$565.6M
Q4 2021125$1.17B
Q3 2021113$1.18B
Q2 2021104$1.05B
Q1 2021101$1.29B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding NRIX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Farther Finance Advisors, LLC0$00.00%−14−100.0%Sold out
IFP Advisors, Inc0$00.00%−6−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Hanseatic Management Services Inc––––Not filed